Morus Inc. (CEO: Ryo Sato; Head Office: Chiyoda-ku, Tokyo; hereinafter “Morus”), whose vision is “Crafting through Tradition, Thriving with Nutrition,” is pleased to announce that KAIKO DNJ+, a product from our wellness brand KAIKO, has been included in the Health Sciences Authority (hereinafter “HSA”) of Singapore’s “List of Notified Complementary Health Products.” The notification was submitted by our Singapore subsidiary, Morus SG Pte. Ltd. (hereinafter “Morus SG”). The declared claim is “Helps support healthy blood sugar levels”. This is the product claim declared by Morus SG for KAIKO DNJ+ and shown in its entry on HSA’s List of Notified Complementary Health Products.
Summary
– Product: KAIKO DNJ+
– Notifying company: Morus SG Pte. Ltd. (Singapore subsidiary of Morus Inc.)
– Listing authority: Health Sciences Authority (HSA), Singapore
– Listing scheme: Voluntary Notification System (a company self-declaration framework)
– Reference page: List of Notified Complementary Health Products (HSA official website)
– Declared claim: “Helps support healthy blood sugar levels”
HSA’s Voluntary Notification System allows companies to declare that their products comply with the published safety, quality, and labelling standards for Complementary Health Products, and to have that declaration published for public reference. With KAIKO DNJ+ now included, the product information declared by Morus SG is publicly viewable on HSA’s official database.
With Morus SG as our hub in Singapore, Morus will continue to bridge traditional Japanese heritage with modern biotechnology, and to deliver safe, transparent, and science-backed wellness solutions to consumers across Southeast Asia and beyond.
<Important note>
Please note that this acknowledgement is not to be construed as an endorsement of the product or used for its advertisement or sales promotion. This listing is not a guarantee of efficacy or an endorsement from HSA — it reflects transparency: the information we have declared is on record and publicly available for reference. The claim above was declared by Morus SG and has not been evaluated or approved by HSA.
About Morus SG
Morus SG is Morus’s base in Singapore. It is the locally registered company responsible for placing KAIKO products on the Singapore market. Under HSA’s Voluntary Notification System, only a company registered in Singapore can submit a notification, so Morus SG made this submission.
This press release has also been published on VRITIMES
You may also like
-
Fourier Rehab Expands Its Vision for Wellness Through Intelligent Robotics at MEDICA 2026
-
Liquid Group and NETSTARS Launch Cross-Border QR Payments in Japan Through RoamQRTM and JPQR Global
-
Starring and Executive Produced by Yuzuru Hanyu “REALIVE”: Connecting the Past and Future of ICE STORY Day Two of the Encore Performances to Be Broadcast Live in Cinemas in Japan and overseas!
-
Yulia Saksen of Creativeans Shares Brand Localisation Insights at Expand Into ASEAN: Indonesia
-
Maison Kojira Launches First Collection of Clean-Label Gourmet Salts
Meracik Cita Rasa Kumamoto di Bali, Tonton Ramen Kini Hadir di Renon Avenue
Morus’s Singapore Subsidiary, Morus SG, Lists KAIKO DNJ+ on Singapore HSA’s List of Notified Complementary Health Products
Fourier Rehab Expands Its Vision for Wellness Through Intelligent Robotics at MEDICA 2026